ENT Devices – Market Insights – Europe

The European ENT device market is a relatively mature market, and overall growth will be driven mainly by the faster-growing nasal packing and balloon dilation device segments. Expansion of these two segments will stem from marginally rising FESS procedure volumes, a shift to the use of resorbable nasal packing, and increased adoption of balloon Eustachian tube dilation. However, ENT procedure volumes will grow only marginally in Europe through 2032, hampered by ongoing efforts to promote the timely detection of ENT conditions, which allows for the use of alternative treatments like antibiotics rather than surgery. As a result, the overall ENT device market will only expand slightly through 2032.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for ENT devices in Europe from 2019 through 2032.

The number of ENT procedures performed will only grow marginally through 2032.

Which procedure types are seeing a decline, and which ones are growing?

How will the dynamics across the ENT procedure types ultimately impact market growth?

What are the forces driving or hampering growth of the various ENT procedure types in Europe?

The introduction of innovative devices such as newer treatments for ENT conditions, such as balloon dilation will drive overall market expansion.

How will balloon sinus dilation and balloon Eustachian tube dilation devices perform going forward?

How will trends in the balloon dilation device market impact other segments in the ENT device space?

Manufacturers are attempting to broaden their portfolios by entering into newer segments, creating competition for established market leaders.

Which segments are seeing competitors with new products emerge?

How have recent mergers and acquisitions affected competitors’ existing product portfolios?

How will these changes impact competitive dynamics in the ENT device market?

Table of contents